Loading…
Risk factors associated with venous thromboembolism in breast cancer: a narrative review
Purpose To date, there is no universally acceptable risk assessment tool in clinical practice that accurately estimates the risk of venous thromboembolism (VTE) in patients with breast cancer, despite the large number of published studies. Thus, the aim of this narrative review was to summarize the...
Saved in:
| Published in: | Supportive care in cancer 2022-10, Vol.30 (10), p.8589-8597 |
|---|---|
| Main Authors: | , , , |
| Format: | Article |
| Language: | English |
| Subjects: | |
| Citations: | Items that this one cites Items that cite this one |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| cited_by | cdi_FETCH-LOGICAL-c372t-3341962a13dd7129f0c7a01285067b1deba1ff52f155a2df5711fe4d7ba891aa3 |
|---|---|
| cites | cdi_FETCH-LOGICAL-c372t-3341962a13dd7129f0c7a01285067b1deba1ff52f155a2df5711fe4d7ba891aa3 |
| container_end_page | 8597 |
| container_issue | 10 |
| container_start_page | 8589 |
| container_title | Supportive care in cancer |
| container_volume | 30 |
| creator | Razouki, Zayd Adnan Ali, Nadeen T. Nguyen, Vinh Q. Escalante, Carmen P. |
| description | Purpose
To date, there is no universally acceptable risk assessment tool in clinical practice that accurately estimates the risk of venous thromboembolism (VTE) in patients with breast cancer, despite the large number of published studies. Thus, the aim of this narrative review was to summarize the most relevant risk factors for VTE in these patients.
Methods
We searched Ovid Embase and Ovid MEDLINE, from inception to March 26, 2021, to identify all articles that focused on breast cancer and multiple thromboembolic diseases. We also searched the references section of relevant articles to identify studies. We did not include case reports or case series with small sample size,
N
|
| doi_str_mv | 10.1007/s00520-022-07045-y |
| format | article |
| fullrecord | <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_2660100077</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A719828916</galeid><sourcerecordid>A719828916</sourcerecordid><originalsourceid>FETCH-LOGICAL-c372t-3341962a13dd7129f0c7a01285067b1deba1ff52f155a2df5711fe4d7ba891aa3</originalsourceid><addsrcrecordid>eNp9kVFrFTEQhYMo9lr9Az5IwBdfts4km81d30qpVigIouBbmN2dtKm7m5rsveX-e1Nva1FEQghMvnNmkiPES4QjBLBvM4BRUIFSFVioTbV7JFZYa11ZrdvHYgVtjVWtjTkQz3K-AkBrjXoqDkoJUQOsxLfPIX-Xnvolpiwp59gHWniQN2G5lFue4ybL5TLFqYtc9hjyJMMsu8SUF9nT3HN6J0nOlBItYcsy8TbwzXPxxNOY-cXdeSi-vj_9cnJWnX_68PHk-LzqtVVLpXWNbaMI9TBYVK2H3hKgWhtobIcDd4TeG-XRGFKDNxbRcz3YjtYtEulD8Wbve53ijw3nxU0h9zyONHOZ3ammgfJbYG1BX_-FXsVNmst0TllcA7S6aR-oCxrZhdnHJVF_a-qOLbZrVfo2hTr6B1XWwFPo48w-lPofArUX9CnmnNi76xQmSjuH4G7jdPs4XYnT_YrT7Yro1d3Em27i4bfkPr8C6D2Qy9V8wenhSf-x_QnkS6lk</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2718009369</pqid></control><display><type>article</type><title>Risk factors associated with venous thromboembolism in breast cancer: a narrative review</title><source>Social Science Premium Collection</source><source>Sociology Collection</source><source>Springer Link</source><creator>Razouki, Zayd Adnan ; Ali, Nadeen T. ; Nguyen, Vinh Q. ; Escalante, Carmen P.</creator><creatorcontrib>Razouki, Zayd Adnan ; Ali, Nadeen T. ; Nguyen, Vinh Q. ; Escalante, Carmen P.</creatorcontrib><description>Purpose
To date, there is no universally acceptable risk assessment tool in clinical practice that accurately estimates the risk of venous thromboembolism (VTE) in patients with breast cancer, despite the large number of published studies. Thus, the aim of this narrative review was to summarize the most relevant risk factors for VTE in these patients.
Methods
We searched Ovid Embase and Ovid MEDLINE, from inception to March 26, 2021, to identify all articles that focused on breast cancer and multiple thromboembolic diseases. We also searched the references section of relevant articles to identify studies. We did not include case reports or case series with small sample size,
N
< 20.
Results
VTE in patients with breast cancer was strongly associated with patient-, tumor-, and non-tumor-related risk factors, such as age, disease stage, central catheter placement, and chemotherapy and tamoxifen use, especially within 2 years of breast cancer diagnosis. CDK inhibitors are emerging factors that may also increase the risk of VTE.
Conclusions
The risk of VTE in patients with breast cancer depends on various patient-, tumor-, and non-tumor-related risk factors. Identifying these risk factors during breast cancer diagnosis and treatment is essential in developing a practical dynamic predictive tool that can help individualize strategies to prevent VTE.</description><identifier>ISSN: 0941-4355</identifier><identifier>EISSN: 1433-7339</identifier><identifier>DOI: 10.1007/s00520-022-07045-y</identifier><identifier>PMID: 35511300</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer Berlin Heidelberg</publisher><subject>Breast cancer ; Cancer ; Chemotherapy ; Medical diagnosis ; Medicine ; Medicine & Public Health ; Nursing ; Nursing Research ; Oncology ; Oncology, Experimental ; Pain Medicine ; Patients ; Pulmonary embolisms ; Rehabilitation Medicine ; Review Article ; Risk assessment ; Risk factors ; Tamoxifen ; Thromboembolism ; Thrombosis</subject><ispartof>Supportive care in cancer, 2022-10, Vol.30 (10), p.8589-8597</ispartof><rights>The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2022</rights><rights>2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.</rights><rights>COPYRIGHT 2022 Springer</rights><rights>The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2022.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c372t-3341962a13dd7129f0c7a01285067b1deba1ff52f155a2df5711fe4d7ba891aa3</citedby><cites>FETCH-LOGICAL-c372t-3341962a13dd7129f0c7a01285067b1deba1ff52f155a2df5711fe4d7ba891aa3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2718009369/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$H</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2718009369?pq-origsite=primo$$EHTML$$P50$$Gproquest$$H</linktohtml><link.rule.ids>314,778,782,21381,21382,27911,27912,33598,33599,34517,34518,43720,44102,73976,74394</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35511300$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Razouki, Zayd Adnan</creatorcontrib><creatorcontrib>Ali, Nadeen T.</creatorcontrib><creatorcontrib>Nguyen, Vinh Q.</creatorcontrib><creatorcontrib>Escalante, Carmen P.</creatorcontrib><title>Risk factors associated with venous thromboembolism in breast cancer: a narrative review</title><title>Supportive care in cancer</title><addtitle>Support Care Cancer</addtitle><addtitle>Support Care Cancer</addtitle><description>Purpose
To date, there is no universally acceptable risk assessment tool in clinical practice that accurately estimates the risk of venous thromboembolism (VTE) in patients with breast cancer, despite the large number of published studies. Thus, the aim of this narrative review was to summarize the most relevant risk factors for VTE in these patients.
Methods
We searched Ovid Embase and Ovid MEDLINE, from inception to March 26, 2021, to identify all articles that focused on breast cancer and multiple thromboembolic diseases. We also searched the references section of relevant articles to identify studies. We did not include case reports or case series with small sample size,
N
< 20.
Results
VTE in patients with breast cancer was strongly associated with patient-, tumor-, and non-tumor-related risk factors, such as age, disease stage, central catheter placement, and chemotherapy and tamoxifen use, especially within 2 years of breast cancer diagnosis. CDK inhibitors are emerging factors that may also increase the risk of VTE.
Conclusions
The risk of VTE in patients with breast cancer depends on various patient-, tumor-, and non-tumor-related risk factors. Identifying these risk factors during breast cancer diagnosis and treatment is essential in developing a practical dynamic predictive tool that can help individualize strategies to prevent VTE.</description><subject>Breast cancer</subject><subject>Cancer</subject><subject>Chemotherapy</subject><subject>Medical diagnosis</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Nursing</subject><subject>Nursing Research</subject><subject>Oncology</subject><subject>Oncology, Experimental</subject><subject>Pain Medicine</subject><subject>Patients</subject><subject>Pulmonary embolisms</subject><subject>Rehabilitation Medicine</subject><subject>Review Article</subject><subject>Risk assessment</subject><subject>Risk factors</subject><subject>Tamoxifen</subject><subject>Thromboembolism</subject><subject>Thrombosis</subject><issn>0941-4355</issn><issn>1433-7339</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>ALSLI</sourceid><sourceid>HEHIP</sourceid><sourceid>M2R</sourceid><sourceid>M2S</sourceid><recordid>eNp9kVFrFTEQhYMo9lr9Az5IwBdfts4km81d30qpVigIouBbmN2dtKm7m5rsveX-e1Nva1FEQghMvnNmkiPES4QjBLBvM4BRUIFSFVioTbV7JFZYa11ZrdvHYgVtjVWtjTkQz3K-AkBrjXoqDkoJUQOsxLfPIX-Xnvolpiwp59gHWniQN2G5lFue4ybL5TLFqYtc9hjyJMMsu8SUF9nT3HN6J0nOlBItYcsy8TbwzXPxxNOY-cXdeSi-vj_9cnJWnX_68PHk-LzqtVVLpXWNbaMI9TBYVK2H3hKgWhtobIcDd4TeG-XRGFKDNxbRcz3YjtYtEulD8Wbve53ijw3nxU0h9zyONHOZ3ammgfJbYG1BX_-FXsVNmst0TllcA7S6aR-oCxrZhdnHJVF_a-qOLbZrVfo2hTr6B1XWwFPo48w-lPofArUX9CnmnNi76xQmSjuH4G7jdPs4XYnT_YrT7Yro1d3Em27i4bfkPr8C6D2Qy9V8wenhSf-x_QnkS6lk</recordid><startdate>20221001</startdate><enddate>20221001</enddate><creator>Razouki, Zayd Adnan</creator><creator>Ali, Nadeen T.</creator><creator>Nguyen, Vinh Q.</creator><creator>Escalante, Carmen P.</creator><general>Springer Berlin Heidelberg</general><general>Springer</general><general>Springer Nature B.V</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>0-V</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88J</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ALSLI</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HEHIP</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>M2R</scope><scope>M2S</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>20221001</creationdate><title>Risk factors associated with venous thromboembolism in breast cancer: a narrative review</title><author>Razouki, Zayd Adnan ; Ali, Nadeen T. ; Nguyen, Vinh Q. ; Escalante, Carmen P.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c372t-3341962a13dd7129f0c7a01285067b1deba1ff52f155a2df5711fe4d7ba891aa3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Breast cancer</topic><topic>Cancer</topic><topic>Chemotherapy</topic><topic>Medical diagnosis</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Nursing</topic><topic>Nursing Research</topic><topic>Oncology</topic><topic>Oncology, Experimental</topic><topic>Pain Medicine</topic><topic>Patients</topic><topic>Pulmonary embolisms</topic><topic>Rehabilitation Medicine</topic><topic>Review Article</topic><topic>Risk assessment</topic><topic>Risk factors</topic><topic>Tamoxifen</topic><topic>Thromboembolism</topic><topic>Thrombosis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Razouki, Zayd Adnan</creatorcontrib><creatorcontrib>Ali, Nadeen T.</creatorcontrib><creatorcontrib>Nguyen, Vinh Q.</creatorcontrib><creatorcontrib>Escalante, Carmen P.</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Social Sciences Premium Collection</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>ProQuest Health and Medical</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Social Science Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>Social Science Premium Collection</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Sociology Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Social Science Database</collection><collection>Sociology Database</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>Supportive care in cancer</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Razouki, Zayd Adnan</au><au>Ali, Nadeen T.</au><au>Nguyen, Vinh Q.</au><au>Escalante, Carmen P.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Risk factors associated with venous thromboembolism in breast cancer: a narrative review</atitle><jtitle>Supportive care in cancer</jtitle><stitle>Support Care Cancer</stitle><addtitle>Support Care Cancer</addtitle><date>2022-10-01</date><risdate>2022</risdate><volume>30</volume><issue>10</issue><spage>8589</spage><epage>8597</epage><pages>8589-8597</pages><issn>0941-4355</issn><eissn>1433-7339</eissn><abstract>Purpose
To date, there is no universally acceptable risk assessment tool in clinical practice that accurately estimates the risk of venous thromboembolism (VTE) in patients with breast cancer, despite the large number of published studies. Thus, the aim of this narrative review was to summarize the most relevant risk factors for VTE in these patients.
Methods
We searched Ovid Embase and Ovid MEDLINE, from inception to March 26, 2021, to identify all articles that focused on breast cancer and multiple thromboembolic diseases. We also searched the references section of relevant articles to identify studies. We did not include case reports or case series with small sample size,
N
< 20.
Results
VTE in patients with breast cancer was strongly associated with patient-, tumor-, and non-tumor-related risk factors, such as age, disease stage, central catheter placement, and chemotherapy and tamoxifen use, especially within 2 years of breast cancer diagnosis. CDK inhibitors are emerging factors that may also increase the risk of VTE.
Conclusions
The risk of VTE in patients with breast cancer depends on various patient-, tumor-, and non-tumor-related risk factors. Identifying these risk factors during breast cancer diagnosis and treatment is essential in developing a practical dynamic predictive tool that can help individualize strategies to prevent VTE.</abstract><cop>Berlin/Heidelberg</cop><pub>Springer Berlin Heidelberg</pub><pmid>35511300</pmid><doi>10.1007/s00520-022-07045-y</doi><tpages>9</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0941-4355 |
| ispartof | Supportive care in cancer, 2022-10, Vol.30 (10), p.8589-8597 |
| issn | 0941-4355 1433-7339 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2660100077 |
| source | Social Science Premium Collection; Sociology Collection; Springer Link |
| subjects | Breast cancer Cancer Chemotherapy Medical diagnosis Medicine Medicine & Public Health Nursing Nursing Research Oncology Oncology, Experimental Pain Medicine Patients Pulmonary embolisms Rehabilitation Medicine Review Article Risk assessment Risk factors Tamoxifen Thromboembolism Thrombosis |
| title | Risk factors associated with venous thromboembolism in breast cancer: a narrative review |
| url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-15T16%3A17%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Risk%20factors%20associated%20with%20venous%20thromboembolism%20in%20breast%20cancer:%20a%20narrative%20review&rft.jtitle=Supportive%20care%20in%20cancer&rft.au=Razouki,%20Zayd%20Adnan&rft.date=2022-10-01&rft.volume=30&rft.issue=10&rft.spage=8589&rft.epage=8597&rft.pages=8589-8597&rft.issn=0941-4355&rft.eissn=1433-7339&rft_id=info:doi/10.1007/s00520-022-07045-y&rft_dat=%3Cgale_proqu%3EA719828916%3C/gale_proqu%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c372t-3341962a13dd7129f0c7a01285067b1deba1ff52f155a2df5711fe4d7ba891aa3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2718009369&rft_id=info:pmid/35511300&rft_galeid=A719828916&rfr_iscdi=true |